MKI67 and hepatocellular carcinoma: Tony et al. suggested that IGF2BP1 functions as a novel potential target to inhibit proliferation and induce apoptosis, partially by downregulating c-MYC mRNA and Ki-67 protein levels during HCC treatment [41].